Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Holst

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The AAPS Journal|September 4, 2024
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous InjectionMark Klitgaard Nøhr, Shaik Rizwan Waheed, Rasmus Juul Kildemoes, et al.
British Journal of Clinical Pharmacology|June 23, 2023
Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort studySissel Haslund-Krog, Jessica M Barry, Angela K Birnbaum, et al.
Neuromuscular Disorders : NMD|December 5, 2023
Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicityMarie Mostue Naume, Qiaolin Zhao, Sissel Sundell Haslund-Krog, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Paracetamol and its metabolites in children and adults with spinal muscular atrophy - a population pharmacokinetic modelQiaolin Zhao, Marie Mostue Naume, Brenda C M de Winter, et al.
Haematologica|May 28, 2021
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemiaRikke Hebo Larsen, Cecilie Utke Rank, Kathrine Grell, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The AAPS Journal|September 4, 2024
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous InjectionMark Klitgaard Nøhr, Shaik Rizwan Waheed, Rasmus Juul Kildemoes, et al.
British Journal of Clinical Pharmacology|June 23, 2023
Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort studySissel Haslund-Krog, Jessica M Barry, Angela K Birnbaum, et al.
Neuromuscular Disorders : NMD|December 5, 2023
Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicityMarie Mostue Naume, Qiaolin Zhao, Sissel Sundell Haslund-Krog, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Paracetamol and its metabolites in children and adults with spinal muscular atrophy - a population pharmacokinetic modelQiaolin Zhao, Marie Mostue Naume, Brenda C M de Winter, et al.
Haematologica|May 28, 2021
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemiaRikke Hebo Larsen, Cecilie Utke Rank, Kathrine Grell, et al.
Pageof 4